Limited disease small cell lung cancer: alternating combination of doxorubicin, etoposide, ifosfamide and hyperfractionated radiotherapy: Final results of a multicentric pilot study from the Groupe Lyonnais d'Oncologie Thoracique (GLOT)
- 31 October 1993
- journal article
- clinical trial
- Published by Elsevier in Lung Cancer
- Vol. 10 (1-2) , 35-45
- https://doi.org/10.1016/0169-5002(93)90307-j
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Hyperfractionated radiotherapy alternating with multidrug chemotherapy in the treatment of limited small cell lung cancer (SCLC)☆International Journal of Radiation Oncology*Biology*Physics, 1990
- Ten-year survival of patients with small-cell lung cancer treated with combination chemotherapy with or without irradiation.Journal of Clinical Oncology, 1990
- A preliminary report: Concurrent twice-daily radiotherapy plus platinum-etoposide chemotherapy for limited small cell lung cancerInternational Journal of Radiation Oncology*Biology*Physics, 1988
- Chemotherapy Alone or Chemotherapy with Chest Radiation Therapy in Limited Stage Small Cell Lung CancerAnnals of Internal Medicine, 1987
- Chemotherapy with or without Radiation Therapy in Limited Small-Cell Carcinoma of the LungNew England Journal of Medicine, 1987
- New drugs in small-cell lung cancerCancer Treatment Reviews, 1986
- Alternating radiotherapy and chemotherapy schedules in small cell lung cancer, limited diseaseInternational Journal of Radiation Oncology*Biology*Physics, 1985
- Biologic basis for altered fractionation schemesCancer, 1985
- Therapeutic effects of single-push or fractionated injections of cyclophosphamide or ifosfamide combined with mesnaCancer Treatment Reviews, 1983
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958